Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multinational, Multicenter Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of Balinatunfib in Adults With Crohn's Disease or Ulcerative Colitis

NCT07222189 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT07222189
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07222189 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multinational, Multicenter Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of Balinatunfib in Adults With Crohn's Disease or Ulcerative Colitis
Lead sponsor
Sanofi
Phase
Phase 2
Overall status
Active, not recruiting
Start date
May 19, 2026
Completion date
October 14, 2026
Enrollment
325 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

colitis ulcerative, crohn's disease